Wound-directed Angiosome RevasculaRIzation apprOach to patients with cRitical limb iSchemia -Prospective multicenter observational study-

Wound-directed Angiosome RevasculaRIzation apprOach to patients with cRitical limb iSchemia -Prospective multicenter observational study- - WARRIORS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029535

Enrollment

450

Registered

2017-10-13

Start date

2017-09-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with peripheral artery disease (PAD) associated with critical limbs ischemia (CLI)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: a) Patients who can provide an informed consent and are aged 20 years or older when providing the consent b) Patients had ischemic foot ulcer or gangrene with SPP<40 mmHg c) Patient who evaluate ABI value before revascularization d) Patient who receive infrapopliteal revascularization for limb salbage

Exclusion criteria

Exclusion criteria: a) Acute limb ischemia or critical limb ischemia due to non-atherosclerotic disease b) CLI with unsalvageable tissue loss extended to beyond ankle c) CLI with planed major amputation

Design outcomes

Primary

Measure	Time frame
12-month wound healing rate	—

Countries

Japan

Contacts

Public ContactKaori Shimogama

Japan Endovascular Treatment Conference Office of WARRIORS Registry

secretariat@j-et.jp092-834-2815

Outcome results